NAV
$45.44
AUM
$1.1B
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.97
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +5.94% | +2.11% | +5.36% | +16.06% | +17.00% | - |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ASML | ASML Holding NV ADR | 2.48% |
| 2 | ROP.SW | Roche Holding AG Ordinary Shares new | 1.15% |
| 3 | NVS | Novartis AG ADR | 1.08% |
| 4 | RY | Royal Bank of Canada | 1.07% |
| 5 | AZN.L | AstraZeneca PLC | 0.85% |
| 6 | RR.L | Rolls-Royce Holdings PLC | 0.72% |
| 7 | ENR.DE | Siemens Energy AG Ordinary Shares | 0.61% |
| 8 | MC.PA | Lvmh Moet Hennessy Louis Vuitton SE | 0.61% |
| 9 | SU.PA | Schneider Electric SE | 0.61% |
| 10 | 6098.T | Recruit Holdings Co Ltd | 0.57% |
The Portfolio is designed to purchase a broad and diverse group of securities of non-U.S. companies in developed markets. The Portfolio invests in companies of all sizes, with increased exposure to smaller capitalization, lower relative price, and higher profitability companies as compared to their representation in the International Universe, while adjusting the composition of the Portfolio based on sustainability impact considerations.
Inception Date: 2022-11-01